A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).

Details

Language :

English

ISSN :

1569-8041

Volume :

29

Issue :

7

Database :

MEDLINE

Journal :

Annals of oncology : official journal of the European Society for Medical Oncology

Publication Type :

Academic Journal

Accession number :

29300804

Full Text :

https://doi.org/10.1093/annonc/mdx801